Trial reportBMC pediatrics2014
Home-based, early intervention with mechatronic toys for preterm infants at risk of neurodevelopmental disorders (CARETOY): a RCT protocol.
Trial report in BMC pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01990183 (CareToy - A Modular Smart System for Infants' Rehabilitation at Home Based on Mechatronic Toys), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
CareToy - A Modular Smart System for Infants' Rehabilitation at Home Based on Mechatronic Toys
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.The Cochrane database of systematic reviews · 2024Pooled it
- Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.The Cochrane database of systematic reviews · 2015Pooled it
- Home based early intervention with CareToy-Revised in infants with early brain injury: a randomized controlled trial.Frontiers in medicine · 2026Trial
- Short-term effects of SAFE early intervention approach in infants born preterm: A randomized controlled single-blinded study.Brain and behavior · 2023Trial
- Effects on Parental Stress of Early Home-Based CareToy Intervention in Low-Risk Preterm Infants.Neural plasticity · 2019Trial
- A randomized clinical trial in preterm infants on the effects of a home-based early intervention with the 'CareToy System'.PloS one · 2017Trial
- Article
- Concurrent and predictive validity of the infant motor profile in infants at risk of neurodevelopmental disorders.BMC pediatrics · 2021Article
- Feasibility Analysis of CareToy-Revised Early Intervention in Infants at High Risk for Cerebral Palsy.Frontiers in neurology · 2020Article
- Infant posture and movement analysis using a sensor-supported gym with toys.Medical & biological engineering & computing · 2019Article
- Early intervention at home in infants with congenital brain lesion with CareToy revised: a RCT protocol.BMC pediatrics · 2018Article
- Article
- A new system for quantitative evaluation of infant gaze capabilities in a wide visual field.Biomedical engineering online · 2015Article
- MEMS sensor technologies for human centred applications in healthcare, physical activities, safety and environmental sensing: a review on research activities in Italy.Sensors (Basel, Switzerland) · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreterm infants are at risk for neurodevelopmental disorders, including motor, cognitive or behavioural problems, which may potentially be modified by early intervention. The EU CareToy Project Consortium (http://www.caretoy.eu) has developed a new modular system for intensive, individualized, home-based and family-centred early intervention, managed remotely by rehabilitation staff. A randomised controlled trial (RCT) has been designed to evaluate the efficacy of CareToy training in a first sample of low-risk preterm infants. METHODS/
designThe trial, randomised, multi-center, evaluator-blinded, parallel group controlled, is designed according to CONSORT Statement. Eligible subjects are infants born preterm without major complications, aged 3-9 months of corrected age with specific gross-motor abilities defined by Ages & Stages Questionnaire scores. Recruited infants, whose parents will sign a written informed consent for participation, will be randomized in CareToy training and control groups at baseline (T0). CareToy group will perform four weeks of personalized activities with the CareToy system, customized by the rehabilitation staff. The control group will continue standard care. Infant Motor Profile Scale is the primary outcome measure and a total sample size of 40 infants has been established. Bayley-Cognitive subscale, Alberta Infants Motor Scale and Teller Acuity Cards are secondary outcome measures. All measurements will be performed at T0 and at the end of training/control period (T1). For ethical reasons, after this first phase infants enrolled in the control group will perform the CareToy training, while the training group will continue standard care. At the end of open phase (T2) all infants will be assessed as at T1. Further assessment will be performed at 18 months corrected age (T3) to evaluate the long-term effects on neurodevelopmental outcome. Caregivers and rehabilitation staff will not be blinded whereas all the clinical assessments will be performed, videotaped and scored by blind assessors. The trial is ongoing and it is expected to be completed by April 2015. DISCUSSION: This paper describes RCT methodology to evaluate CareToy as a new tool for early intervention in preterm infants, first contribution to test this new type of system. It presents background, hypotheses, outcome measures and trial methodology.
trial registrationClinicalTrials.gov: NCT01990183. EU grant ICT-2011.5.1-287932.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.